India is once again on the top of the pharmaceutical industry’s list of countries that do not provide enough protection of intellectual property rights. But this year it is joined by an unlikely foe: Canada.
The Pharmaceutical Research and Manufacturers of America focused on the two countries at a public hearing of the Office of...
Welcome to Pink Sheet
Create an account to read this article
Already a subscriber?